India to Italy: Busulfan Export Trade Route
India has recorded 11 verified shipments of Busulfan exported to Italy, representing a combined trade value of $111.4K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $10.1K USD. The leading Indian exporter is EMCURE PHARMACEUTICALS LIMITED, which accounts for 76% of total export value with 6 shipments worth $84.1K USD. On the buying side, TILLOMED ITALIA SRL . is the largest importer in Italy with $49.8K USD in purchases. The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Italy Busulfan corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $111.4K USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's busulfan manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $10.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with busulfan's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 17.5%, placing it at rank #14 among India's top busulfan export destinations globally.
On the import side, key buyers of Indian busulfan in Italy include TILLOMED ITALIA SRL ., TILLOMED ITALY SRL, ACCORD HEALTHCARE ITALIA SRL and 2 others. TILLOMED ITALIA SRL . is the single largest importer with 4 shipments valued at $49.8K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#14
- Annual growth+17.5%
- Demand growth+15.1%
- Regulatory ease77/100
Top 10 Indian Busulfan Exporters to Italy
Showing top 10 of 3 Indian suppliers exporting Busulfan to Italy, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED Avg $14.0K per shipment | 6 | $84.1K | 75.5% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $4.1K per shipment | 4 | $16.3K | 14.6% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $10.9K per shipment | 1 | $10.9K | 9.8% |
This table shows the top 10 of 3 Indian companies exporting busulfan to Italy, ranked by total trade value. The listed exporters are: EMCURE PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . EMCURE PHARMACEUTICALS LIMITED is the dominant supplier with 6 shipments worth $84.1K USD, giving it a 76% market share.
Top 10 Busulfan Importers in Italy
Showing top 10 of 5 known buyers in Italy receiving Busulfan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian busulfan in Italy include TILLOMED ITALIA SRL ., TILLOMED ITALY SRL, ACCORD HEALTHCARE ITALIA SRL, ACCORD HEALTHCARE ITALIA SRL , LAB ANALYSIS. The largest importer is TILLOMED ITALIA SRL ., accounting for $49.8K USD across 4 shipments — representing 45% of all busulfan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TILLOMED ITALIA SRL . | 4 | $49.8K | 44.8% |
| 2 | TILLOMED ITALY SRL | 2 | $34.3K | 30.8% |
| 3 | ACCORD HEALTHCARE ITALIA SRL | 1 | $16.2K | 14.6% |
| 4 | ACCORD HEALTHCARE ITALIA SRL | 1 | $10.9K | 9.8% |
| 5 | LAB ANALYSIS | 3 | $81 | 0.1% |
Top 10 Busulfan Formulations Imported by Italy
Showing top 10 of 11 product formulations shipped on the India to Italy Busulfan route, ranked by trade value
Italy imports a wide range of busulfan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — MEDICINES BUSULFAN INJECTION 60mg/10mL : BATCH NO. ESD25004B, MFG: Feb 2025, EXP: Jan 2027 (PACKS) — accounts for $43.3K USD across 1 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDICINES BUSULFAN INJECTION 60mg/10mL : BATCH NO. ESD25004B, MFG: Feb 2025, EXP: Jan 2027 (PACKS) | 1 | $43.3K | 38.9% |
| 2 | MEDICINES BUSULFAN INJ 60mg/10mL 1CRT TILLO IT : BATCH NO. : ESD25016A , MFG: Mar 2025 , EXP: Feb 2027 | 1 | $34.3K | 30.8% |
| 3 | PHARMA DRUGS & MEDI: BUSULFAN INJ,6MG/ML,10MLX8V(ACCORD-ITALY 284X1X8VIALVLS | 1 | $16.2K | 14.6% |
| 4 | PHARMA DRUGS & MEDI BUSULFAN INJ,6MG/ML, | 1 | $10.9K | 9.8% |
| 5 | MEDICINES BUSULFAN INJECTION 60mg/10mL : BATCH NO. ESD25012C, MFG: Feb 2025, EXP: Jan 2027 (PACKS) | 1 | $6.5K | 5.9% |
| 6 | BUSULFAN INJECTION USP 6MG/ML, 10ML BATCH NO. : M2315066 MFG. DATE : 12.2023 & EXP. DATE : 11.2025NOS | 1 | $30 | 0.0% |
| 7 | BUSULFAN INJECTION USP 6MG/ML, 10ML BATCH NO. : M2401287 MFG. DATE : 02.2024 & EXP. DATE : 01.2026 | 1 | $26 | 0.0% |
| 8 | BUSULFAN INJECTION 6MG/ML, 10ML BATCH NO. : M2405624 MFG. DATE : 06.2024 & EXP.DATE : 05.2026 | 1 | $25 | 0.0% |
| 9 | MEDICINES BUSULFAN INJECTION 60mg/10mL : BATCH NO. ESD25004B, MFG: Feb 2025, EXP: Jan 2027 (PACKS) (FOC) | 1 | $0 | 0.0% |
| 10 | MEDICINES BUSULFAN INJECTION 60mg/10mL : BATCH NO. ESD25012C, MFG: Feb 2025, EXP: Jan 2027 (PACKS)(FOC) | 1 | $0 | 0.0% |
Showing top 10 of 11 Busulfan formulations imported by Italy on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 6 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's busulfan exports to Italy are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Italy benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $10.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as medicines busulfan inj 60mg/10ml 1crt tillo it : batch no. : esd25016a , mfg: mar 2025 , exp: feb 2027 and pharma drugs & medi: busulfan inj,6mg/ml,10mlx8v(accord-italy 284x1x8vialvls, suggesting that buyers in Italy tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TILLOMED ITALIA SRL . is the largest importer with 4 shipments worth $49.8K USD — representing 45% of all busulfan imports from India on this route.
Route Statistics
- Trade Volume
- $111.4K
- Avg. Shipment
- $10.1K
- Suppliers
- 3
- Buyers
- 5
- Transit (Sea)
- ~27 days
- Annual Growth
- +17.5%
Other Busulfan Routes
Unlock the Full India to Italy Busulfan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — India to Italy Busulfan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Busulfan to Italy?
The leading Indian exporters of Busulfan to Italy are EMCURE PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . EMCURE PHARMACEUTICALS LIMITED holds the largest market share at approximately 76% of total trade value on this route.
Q What is the total value of Busulfan exports from India to Italy?
India exports Busulfan to Italy worth approximately $111.4K USD across 11 recorded shipments. The average value per shipment is $10.1K USD.
Q Which ports does India use to ship Busulfan to Italy?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 6 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Italy for Busulfan?
The average transit time for Busulfan shipments from India to Italy is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Italy Busulfan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.5% with demand growth tracking at 15.1%. The route is ranked #14 among India's top Busulfan export destinations globally.
Q How many suppliers are active on the India to Italy Busulfan route?
There are currently 3 active Indian suppliers exporting Busulfan to Italy. The market is moderately concentrated with EMCURE PHARMACEUTICALS LIMITED accounting for 76% of total shipment value.
Q Who are the main importers of Busulfan from India in Italy?
The leading importers of Indian Busulfan in Italy include TILLOMED ITALIA SRL ., TILLOMED ITALY SRL, ACCORD HEALTHCARE ITALIA SRL, ACCORD HEALTHCARE ITALIA SRL , LAB ANALYSIS. TILLOMED ITALIA SRL . is the largest buyer with 4 shipments worth $49.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Italy export trade corridor identified from Indian Customs (DGFT) records for Busulfan.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 5 importers in Italy matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists